Three items of pandemic news: Long Covid in children; an FDA panel confirms an excess of heart inflammation following mRNA vaccination; and how the American tendency to individualism over collectivism hamstrung our pandemic response. Plus news briefs and a frippery. … Continue reading →
Items of recent pandemic news: Moderna’s vaccine works in those 12 to 17 years old; the political nature of college mandates to vaccinate returning students; and a new, fast-spreading variant out of India. Plus news briefs and a frippery. B.1.617.2 … Continue reading →
Herewith three items of recent pandemic news: More studies on mixing vaccine doses; the FDA extends Pfizer’s authorization to ages 12+; and acknowledgement from the CDC that this virus is airborne. Plus news briefs and a frippery. It is indeed … Continue reading →
Belatedly, three items of recent pandemic news: Novavax and the EU; a detailed study of long haulers in the VA health care system; and the imminent authorization of Pfizer’s vaccine for young adolescents. Plus news briefs and a frippery. Authorization … Continue reading →
Herewith three items of pandemic news you may have missed recently: Disparate theories of long Covid; Europe locks in 1.8 billion Pfizer doses; and the troubles attendant upon Russia’s Sputnik V vaccine. Plus news briefs and a frippery. Russia’s Sputnik … Continue reading →
Herewith three items of pandemic news you may have missed recently: Covid-19 can damage the brain without infecting it; what’s up with the blood clots; and the FDA shuts down Emergent’s Baltimore operation. Plus news briefs and a frippery. FDA … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
Herewith three items of pandemic news you may have missed recently: The latest installment in the ongoing AstraZeneca saga; how the immunosuppressed respond to mRNA vaccination; and Minnesota’s opening up of eligibility for shots. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Reinfection is more likely after age 65; the EU gives AstraZeneca’s vaccine a less than resounding go-ahead; and long Covid in children. Plus news briefs and a frippery. Long … Continue reading →
Three items of pandemic news you may have missed recently: Kids and Covid-19; enhanced lethality of the B.1.1.7 variant; and more on the pause in AstraZeneca shots as Europe investigates a rare condition. Plus news briefs and a frippery. AstraZeneca … Continue reading →
